The use of recombinant factor VIIa in severe postpartum hemorrhage.
Segal
Shmuel
S
Barzilai Medical Center, Ashkelon, Israel.
Shemesh
Iftah Y
IY
Blumental
Rima
R
Yoffe
Boris
B
Laufer
Neri
N
Mankuta
David
D
Mazor
Moshe
M
Zohar
Shifra
S
Schiff
Eyal
E
Martinovitz
Uri
U
D015942:Factor VIIa / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006487:Hemostasis; D006801:Humans; D006473:Postpartum Hemorrhage / Q000188:drug therapy* / Q000473:pathology; D011247:Pregnancy; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D012720:Severity of Illness Index; D016896:Treatment Outcome
D011994:Recombinant Proteins; D015942:Factor VIIa